Company: AMKR
Filing Date: 2025-04-29
Form Type: 10-Q
Source: 0001047127-25-000087
Chunk: 137

Company: AMKOR TECHNOLOGY, INC.
Filing Date: 2025-04-29
Form: 10-Q
Item: Part I, Item 8
Chunk 137
---
 Operating Decision Maker (CODM):For the Three Months Ended March 31,20252024(In thousands)Interest income$14,453 $16,796 Depreciation and amortization expense153,821 144,925 Total assets6,921,241 6,685,066 Capital expenditures79,897 96,169 The following table presents our net sales by product group:For the Three Months Ended March 31,20252024(In thousands)Advanced products (1)$1,063,617 $1,069,709 Mainstream products (2)257,958 295,802 Total net sales$1,321,575 $1,365,511 (1) Advanced products include flip chip, memory and wafer-level processing and related test services.(2) Mainstream products include all other wirebond packaging and related test services.

-10-

Table of ContentsAMKOR TECHNOLOGY, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)(Unaudited)

Net sales by end market consist of the following:For the Three Months Ended March 31,20252024Communications (smartphones, tablets)40 %47 %Computing (data center, infrastructure, PC/laptop, storage)22 %17 %Automotive, industrial and other (ADAS, electrification, infotainment, safety)21 %22 %Consumer (AR & gaming, connected home, home electronics, wearables)17 %14 %Total net sales100 %100 %

3.    Other Income and Expense 

Other income and expense consist of the following:For the Three Months Ended March 31, 20252024 (In thousands)Interest income$(14,453)$(16,796)Foreign currency (gain) loss, net3,760 1,545 Other, net(382)(44)Total other (income) expense, net$(11,075)$(15,295)

4.    Income Taxes 

Income tax expense of $3.9 million for the three months ended March 31, 2025 reflects income taxes, foreign withholding taxes and minimum taxes.We monitor on an ongoing basis our ability to utilize our deferred tax assets and whether there is a need for a related valuation allowance.  In evaluating our ability to recover our deferred tax assets in the jurisdictions from which they arise, we consider all available positive and negative evidence,